Revolutionizing Cognitive Rehabilitation with Transcranial Direct Current Stimulation: A Novel perspectives in Type 2 Diabetes Mellitus

Background: Mild cognitive impairment (MCI), also referred to as central neuropathy, is considered a new complication of diabetes. It affects approximately $\mathbf{1 0 - 1 5 \%}$ of diabetic individuals, leading to a conversion from cognitive impairment to dementia in some cases. This research aims to assess the effectiveness of transcranial direct current stimulation in treating cognitive impairment. Materials and Methods: This study is a Pre-post experimental design involving 30 diabetic patients diagnosed with cognitive impairment. The study was conducted from September 2022 to December 2022, with recruitment taking place in the diabetic outpatient department of a tertiary care hospital. 200 patients were initially approached, with 30 meeting the inclusion criteria: 35 to 55 years, HbA1c levels between $\mathbf{6. 0 \%}$ to $\mathbf{8. 0} \%$, Montreal Cognitive Assessment scores below 24, and diabetes duration less than 5 years. The participants underwent various outcome assessments, including the Addenbrooke Cognitive Examination scale, Indian version, Montreal Cognitive Assessment, and Stroop test, at two-time points, 0 to 5 weeks apart, with five weekly sessions. Patients with additional health conditions were excluded to minimize potential confounding factors. Results: The study utilized parametric tests, with Student t-tests for the MoCA score and Stroop test, and Wilcoxon signed-rank tests for the ACE-III score, a categorical variable. The results showed an increase in the mean ACE-III score from 42.2 to 48.3, indicating a significant improvement ($\mathbf{p}=\mathbf{0. 0 2}$). Similarly, the mean MoCA score rose from 19.3 to 24.6, showing significant improvement (p=0.03). The mean Stroop test time decreased from 60 seconds ±2 to 8 seconds ±2, demonstrating a significant improvement (p=0.04). Conclusion: The findings suggest that TDCS treatment led to enhancements in memory, visuospatial skills, and concentration. However, there was no notable improvement observed in executive skills and abstract thinking.

Authors

Institutions

Publication Details

Published
2024-10-25
DOI
https://doi.org/10.1109/icisaa62385.2024.10828870
Primary Topic
Transcranial Magnetic Stimulation Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Revolutionizing Cognitive Rehabilitation with Transcranial Direct Current Stimulation: A Novel perspectives in Type 2 Diabetes Mellitus

Abha Khisty, Tushar J. Palekar
Transcranial Magnetic Stimulation Studies
article

Revolutionizing Cognitive Rehabilitation with Transcranial Direct Current Stimulation: A Novel perspectives in Type 2 Diabetes Mellitus

Abha Khisty, Tushar J. Palekar
article en

Abstract

Background: Mild cognitive impairment (MCI), also referred to as central neuropathy, is considered a new complication of diabetes. It affects approximately $\mathbf{1 0 - 1 5 \%}$ of diabetic individuals, leading to a conversion from cognitive impairment to dementia in some cases. This research aims to assess the effectiveness of transcranial direct current stimulation in treating cognitive impairment. Materials and Methods: This study is a Pre-post experimental design involving 30 diabetic patients diagnosed with cognitive impairment. The study was conducted from September 2022 to December 2022, with recruitment taking place in the diabetic outpatient department of a tertiary care hospital. 200 patients were initially approached, with 30 meeting the inclusion criteria: 35 to 55 years, HbA1c levels between $\mathbf{6. 0 \%}$ to $\mathbf{8. 0} \%$, Montreal Cognitive Assessment scores below 24, and diabetes duration less than 5 years. The participants underwent various outcome assessments, including the Addenbrooke Cognitive Examination scale, Indian version, Montreal Cognitive Assessment, and Stroop test, at two-time points, 0 to 5 weeks apart, with five weekly sessions. Patients with additional health conditions were excluded to minimize potential confounding factors. Results: The study utilized parametric tests, with Student t-tests for the MoCA score and Stroop test, and Wilcoxon signed-rank tests for the ACE-III score, a categorical variable. The results showed an increase in the mean ACE-III score from 42.2 to 48.3, indicating a significant improvement ($\mathbf{p}=\mathbf{0. 0 2}$). Similarly, the mean MoCA score rose from 19.3 to 24.6, showing significant improvement (p=0.03). The mean Stroop test time decreased from 60 seconds ±2 to 8 seconds ±2, demonstrating a significant improvement (p=0.04). Conclusion: The findings suggest that TDCS treatment led to enhancements in memory, visuospatial skills, and concentration. However, there was no notable improvement observed in executive skills and abstract thinking.

Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN), Dr. D.Y. Patil Vidyapeeth, Pune (IN)
Good health and well-being
Openalex Percentile: Top 70%
Transcranial Magnetic Stimulation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.